Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$13.05
—
Mkt Cap $1.23B
Analyst Ratings
Buy
6
Hold
4
Sell
0
Price Target (21 analysts)
$18.67
Range $17.00 – $20.00
Implied Upside
+43.1%
Consensus $18.67 vs current $13.05
NASDAQ·Healthcare·Biotechnology
$13.05
—
Mkt Cap $1.23B
Buy
6
Hold
4
Sell
0
Price Target (21 analysts)
$18.67
Range $17.00 – $20.00
+43.1%
Consensus $18.67 vs current $13.05